Exhibit 32(b)


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-QSB for the period ended March  31,  2006
as  filed with the Securities and Exchange Commission (the "Report"),
I,  Edward  J.  Weisberger, Chief Financial Officer of  the  Company,
certify  pursuant to 18 U.S.C. Section 1350, as adopted  pursuant  to
Section  906 of the Sarbanes-Oxley Act of 2002, that, to the best  of
my knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: May 19, 2006                By: /S/ EDWARD J. WEISBERGER
      ____________                    _______________________________
                                          EDWARD J. WEISBERGER
                                          Chief Financial Officer


A  signed original of this written statement required by Section  906
has  been provided to the Company and will be retained by the Company
and  furnished to the Securities and Exchange Commission or its staff
upon request.